Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
December 14, 2017
A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
Christoph Niederalt, Lars Kuepfer, Juri Solodenko, et al.
Clinical Pharmacokinetics
|
May 9, 2018
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Jan-Frederik Schlender, Donato Teutonico, Katrin Coboeken, et al.
Frontiers in Pharmacology
|
June 30, 2020
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
Sumit Basu, Yi Ting Kayla Lien, Valvanera Vozmediano, et al.
Clinical Pharmacokinetics
|
May 4, 2022
Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD
Sebastiaan Camiel Goulooze, Hiddo J L Heerspink, Martijn van Noort, et al.
Clinical Pharmacokinetics
|
October 5, 2019
Population Pharmacokinetic and Exposure-Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease
Nelleke Snelder, Roland Heinig, Henk-Jan Drenth, et al.
Pediatric Cardiology
|
May 9, 2024
NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure
Walter Schmitt, Christian Diedrich, Taye H Hamza, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 15, 2019
Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam
Hannah Britz, Nina Hanke, Anke-Katrin Volz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 17, 2017
Current strategies to streamline pharmacotherapy for older adults
Jan-F Schlender, Valvanera Vozmediano, Adam G Golden, et al.
Clinical Pharmacokinetics
|
November 17, 2021
Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria
Sebastiaan Camiel Goulooze, Nelleke Snelder, Andreas Seelmann, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2021
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt, Hauke Rühs, Rolf Burghaus, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Journal of Pharmacokinetics and Pharmacodynamics
|
December 14, 2017
A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
Christoph Niederalt, Lars Kuepfer, Juri Solodenko, et al.
Clinical Pharmacokinetics
|
May 9, 2018
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Jan-Frederik Schlender, Donato Teutonico, Katrin Coboeken, et al.
Frontiers in Pharmacology
|
June 30, 2020
Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
Sumit Basu, Yi Ting Kayla Lien, Valvanera Vozmediano, et al.
Clinical Pharmacokinetics
|
May 4, 2022
Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD
Sebastiaan Camiel Goulooze, Hiddo J L Heerspink, Martijn van Noort, et al.
Clinical Pharmacokinetics
|
October 5, 2019
Population Pharmacokinetic and Exposure-Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease
Nelleke Snelder, Roland Heinig, Henk-Jan Drenth, et al.
Pediatric Cardiology
|
May 9, 2024
NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure
Walter Schmitt, Christian Diedrich, Taye H Hamza, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 15, 2019
Physiologically-Based Pharmacokinetic Models for CYP1A2 Drug-Drug Interaction Prediction: A Modeling Network of Fluvoxamine, Theophylline, Caffeine, Rifampicin, and Midazolam
Hannah Britz, Nina Hanke, Anke-Katrin Volz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
October 17, 2017
Current strategies to streamline pharmacotherapy for older adults
Jan-F Schlender, Valvanera Vozmediano, Adam G Golden, et al.
Clinical Pharmacokinetics
|
November 17, 2021
Finerenone Dose-Exposure-Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria
Sebastiaan Camiel Goulooze, Nelleke Snelder, Andreas Seelmann, et al.
Clinical Pharmacology and Therapeutics
|
February 25, 2021
NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure
Walter Schmitt, Hauke Rühs, Rolf Burghaus, et al.
Page
of 5